4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-25-009074
EVP, CHIEF FINANCIAL OFFICER sold 3,171 shares at $17.05 ($54,066)
- EVP, CHIEF FINANCIAL OFFICER acquired 6,178 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-03-25 | Option exercise | +6,178 | 60,060 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-03-26 | Sale | −3,171 | $17.05 | $54,066 | 56,889 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-03-24 | Grant or award · Stock Option (Right to Buy) | +110,761 | 110,761 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-03-24 | Grant or award · Restricted Stock Units | +32,552 | 32,552 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2025-03-25 | Option exercise · Restricted Stock Units | −6,178 | 18,536 | D | ||
| Open-market sales · 3,171 sh · avg $17.05 · $54,066 | |||||||
Loading xslF345X05/form4-03272025_120306.xml…